Courses & Training

For a comprehensive calendar of fungal courses and conferences please visit our sister site Aspergillus & Aspergillosis.

 

In-person courses

China-Netherlands Course in Medical Mycology. 18-26 May. Suzhou, China. Email organiser.

BSMM Course in Diagnostic Medical Mycology. 10-14 June. Leeds, UK. Contact organiser.

3rd Workshop on AIDS-related Mycoses. 10-12 July. Cape Town, South Africa. Website.

Better Methods for Clinical Studies in Infectious Diseases and Clinical Microbiology: An ESCMID Hands-on Workshop. 7-9 Nov. Seville, Spain. Website.

Histoplasmosis in the Americas and the Caribbean, 2nd Meeting. Manaus, Brazil. Contact by email or complete this form.

Antimicrobial Stewardship Research Workshop. 14-15 Nov. Maryland, USA. Website.

9th Advances Against Aspergillosis and Mucormycosis (AAA). Lugano, Switzerland. Website.

 

Online courses and MOOCs

Expert presentations on 'Evolving Strategies to Optimise Treatment of Patients with Invasive Mould Infections' and 'Invasive Mould Infections: The Case for Early Diagnosis' can be found here

Using Infection Control to Combat Antimicrobial Resistance (University of East Anglia, via FutureLearn)

Challenges in Antibiotic Resistance: Point Prevalence Surveys (BSAC, via FutureLearn)

Antimicrobial Stewardship: Managing Antibiotic Resistance (University of Dundee, via FutureLearn)

The New Antifungal Toolkit: The Pharmacopeia and Beyond is an Internet CME curriculum that will provide current information about new FDA-approved agents/formulations for the management of invasive fungal infections (IFIs) and evaluate the role of these newer options in strategies to optimize antifungal therapy. As such, the activity will move beyond the typical drug pharmacopeia to address dosing in special populations (eg, pediatrics, patients with renal insufficiency, specific host types), health economic data, as well as comparative effectiveness, where appropriate. The activity will also include a broader pharmacopeia of all FDA-approved agents for invasive mycoses as a useful point of comparison as well as a practice reference. Two updates cover additional FDA approvals and keep the learner up to date as research data for newer agents mature and clinical experience grow. More information

Free online learning opportunity (CME module): Fungal pulmonary infections: pulmonary aspergillosis in non-hematological patients.

Additionally, an online medical mycology course (no fee) is being ran by Errol Reiss, PhD. Please sign up here then email Errol to confirm enrollment.

Mechanisms in Fungal Infections - From the science to the Clinical Setting (E-learning course) — E-learning resource with CME content developed by expert multidisciplinary specialists. Designed for oncologists, hematologists, and infectious disease specialists who treat patient groups at  risk from developing fungal infections More information

The Antifungal Toolkit: The Pharmacopeia and Beyond (University of Nebraska, via Fungus CME)
 

Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action (Global Academy for Medical Education)
 

Physical treatment plus antifungal best for chromoblastomycosis, review finds (Global Academy for Medical Education)

 

Conferences

 

Take action today

Educate

Recognise & treat fungal
infections: See opportunities for
learning.

Spread
the word

Help us change as many
lives as possible by
sharing this site!